Search for: "Food and Drug Administration"
Results 541 - 560
of 23,725
Sort by Relevance
|
Sort by Date
12 Feb 2024, 9:02 pm
The Food and Drug Administration also lists the following food safety measures for those experiencing power outages. [read post]
12 Feb 2024, 9:00 pm
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign countries. [read post]
12 Feb 2024, 4:19 pm
The Food and Drug Administration continues to update its list of recalled products linked to the nationwide outbreak. [read post]
12 Feb 2024, 7:05 am
Food and Drug Administration (FDA) to guide patent examiners in the evaluation and treatment of Rule 132 declarations. [read post]
12 Feb 2024, 6:00 am
Patent and Trademark Office (USPTO), and former heads of NIST itself, across both Democratic and Republican administrations. [read post]
11 Feb 2024, 5:03 am
Food and Drug Administration and the U.S. [read post]
9 Feb 2024, 10:20 pm
The federal government said consumers should consult the Food and Drug Administration’s table of recalled products for updated information about descriptions, sizes and best-by dates. [read post]
9 Feb 2024, 2:35 pm
The Food and Drug Administration has been notified of additional recalls for products made with or containing recalled dairy products from Rizo Lopez Foods Inc. [read post]
9 Feb 2024, 12:03 pm
Its effects increase in a dose-proportional manner, and a steady state is achieved after four to five weeks of once-weekly administration. [read post]
9 Feb 2024, 11:08 am
The Food and Drug Administration (FDA) relies on broad judicial deference granted by Chevron, with the primary goal of utilizing scientific and clinical expertise to protect the health and safety of the public. [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
